Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation preliminary results of a follow-up study

European Archives of Psychiatry and Clinical Neuroscience

Volumn 249, Issue SUPPL. 4, 1999, Pages

  Bottlender, Ronald ^a   Wegner, Ulrike ^a   Wittmann, Johannes ^a   Strauß, Anton ^a   Möller, Hans Jürgen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Deficit syndromes; Follow up study; Prediction of outcome; Schizophrenia

Indexed keywords

ADULT; AGED; CONFERENCE PAPER; EMPLOYMENT; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NEGATIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SYNDROME;

EID: 0343851633     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Arbeitsgemeinschaft für Methodik und Diagnostik in der Psychiatrie (AMDP) (1981) Rev. Aufl. 1995) Manual Zur Dokumentation Psychiatrischer Befunde. 5. Ed. Springer, Berlin Heidelberg New York
2. Angst J, Stassen HH, Woggon B (1989) Effect of neuroleptics on positive and negative symptoms and the deficit state. Psychopharmacology, Berl. 99 Suppl:41-6
3. Angermeyer MC, Kuhn L, Goldstein JM ( 1990) Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull 16(2):293-30
4. Bobon D (1983) Foreign adaptations of the AMDP-System. In: Bobon D, Baumann U, Angst J, Helmchen H and Hippius H (eds) AMDP-System in Pharamcopsychiatry, 19-34. Basel: Karger
5. Bobon D, Woggon B, (1986) The AMDP system in clinical psychopharmacology. Br J Psychiatry 148:467-8
6. Bottlender R, Strauß A, Möller HJ (1999) Prevalence and precipitatin Factors of Depression in first admitted Schizophrenic Patients. Acta psych scand, in press
7. Bottlender R, Strauß A, Möller HJ (1999) Relation between Duration of Symptoms before admission and Treatment Response in 998 first admitted Schizophrenic Patients. Schizophr Res. in press
8. Bottlender R, Mirlach C, Strauß A, Hoff P, Möller HJ (1998) Comparison of AMDP syndromes in schizoaffective psychoses according to ICD-9 and ICD-10 criteria. In: Stieglitz RD, Faehndrich E, Moeller HJ (eds) Syndromale Diagnostik psychischer Stoerungen, Hogrefe, Goettingen, 1998, pp 209-214
9. Carpenter WT Jr, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145(5):578-83
10. Davis KL, Buchsbaum MS, Shihabuddin L, Spiegel-Cohen J, Metzger M, Frecska E, Keefe RS, Powchik P (1998) Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry I: 43(11):783-93
11. Degkwitz R, Helmchen H, Kockott G, Mombour W (1980) Diagnosenschlüssel und Glossar Psychiatrischer Krankheiten. 5. Aufl. Korr. nach der 9. Rev. der ICD. Deutsche Ausgabe der Internationalen Klassifikation der Krankheiten der WHO. ICD 9. Rev. Kap V. Springer, Berlin Heidelberg New York
12. DeLisi LE, Sakuma M, few W, Kushner M, Hoff AL, Grimson R (1997) Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 74(3):129-40
13. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psych 33(6):766-71
14. Fahndrich E, Helmchen H, Hippius H (1983) The history of the AMDP-system. Mod-Probl. Pharmacopsychiatry, 20:1-9
15. Fenton-WS (1997) Course and outcome in schizophrenia. Curr Opin Psychiatry 10/1 (40-44)
16. Fenton WS, McGlashan TH (1989) Testing systems for assessment of negative symptoms in schizophrenia. Arch Gen Psychiatry 49(3):236-7
17. Geddes J, Mercer G, Frith CD, MacMillan F. Owens DG, Johnstone EC (1994) Prediction of outcome following a first episode of schizophrenia. A follow-up study of Northwick Park first episode study subjects. Br J Psychiatry 165(5):664-8
18. Grossman LS, Harrow M, Goldberg JF, Fichtner CG. (1991) Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders. Am J Psychiatry 148(10):1359-65
19. Hafner H, an-der-Heiden W, Behrens S, Gattaz WF, Hambrecht M, Loffler W, Maurer K, Munk-Jorgensen P, Nowotny B. Riecher-Rossler A, Stein A ( 1998) Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull 24(1):99-113
20. Harrison G, Croudace T, Mason P, Glazebrook C, Medley I (1996) Predicting the long-term outcome of schizophrenia. Psychol Med 26(4):697-705
21. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G (1984) One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 151(10):1409-16
22. Johnstone EC, Frith CD, Crow TJ, Owens DG, Done DJ, Baldwin EJ, Charlette A (1992) The Northwick Park 'Functional' Psychosis Study: Diagnosis and outcome. Psychol. Med. 22(2): 331-416
23. Jonsson H, Nyman AK (1991) Predicting long-term outcome in schizophrenia. Acta Psychiatr Scand 83(5):342-6
24. Kirkpatrick B, Buchanan RW, Mckenney PD. Alphs LD, Carpenter WT Jr (1989) The schedule for the deficit syndrome: An instrument for research in schizophrenia. Psychiatry Res 30(2): 119-23
25. Lieberman JA (1993) Prediction of outcome in first-episode schizophrenia. J Clin Psychiatry 54 Suppl: 13-7
26. Lieberman JA, Koreen AR, Chakos M, Sheitman B, Woerner M, Alvir JM, Bilder R, (1996) Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry 57, Suppl 9:5-9
27. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR (1992). Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 149(9):1183-8
28. Mason P, Harrison G, Glazebrook C, Medley I, Croudace T (1996) The course of schizophrenia over 13 years. A report from The International Study On Schizophrenia (Isos) coordinated by the World Health Organization. Br J Psychiatry 169(5):580-6
29. Mayerhoff DI, Loebel AD, Alvir JM, Szymanski SR, Geisler SH, Borenstein M, Lieberman JA (1994) The deficit state in first-episode schizophrenia. Am J Psychiatry 151(10):1417-22
30. McEvoy JP, Schooler NR, Wilson WH (1991) Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacol Bull 27(2):97-101
31. McGlashan TH (1986) The prediction of outcome in chronic schizophrenia. IV. The Chestnut Lodge follow-up study. Arch Gen Psychiatry 43(2):167-76
32. McGlashan TH (1988) A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull 14(4):515-42
33. Miller DB, Ali SF, O'Callaghan JP, Laws SC (1998) The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann N Y Acad Sci 844:153-65
34. Möller HJ, von Zerssen D (1995) Course And Outcome Of Schizophrenia. In: Hirsch SR, Weinberger DR (eds) Schizophrenia. Blackwell Science, 107-27
35. Möller HJ, Schmid Bode W, Cording Tommel C, Wittchen HU, Zaudig M, von Zerssen D ( 1988) Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5-8 year follow-up. Acta Psychiatr Scand 77: 379-389
36. Möller HJ, Hohe Schramm M, Cording Tommel C, Schmid Bode W, Wittchen HU, Zaudig M, von Zerssen D (1989) The classification of functional psychoses and its implications for prognosis. Br J Psychiatry 154:467-472
37. Möller HJ, Schmid Bode W, von Zerssen D (1986) Prediction of long-term outcome in schizophrenia by prognostic scales. Schizophr Bull 12(2):225-34
38. Möller HJ, (1995) The negative component in schizophrenia. Acta Psychiatr Scand, Suppl 388:11-4
39. Mueser KT, Douglas MS, Bellack AS, Morrison RL (1991) Assessment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophr Bull 17(4):565-82
40. Nishino H, Nakajima K, Kumazaki M, Fukuda A, Muramatsu K, Deshpande SB, Inubushi T, Morikawa S, Borlongan CV, Sanberg PR (1998) Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid. Neurosci Res 30(4): 303-12
41. Pietzcker A, Gebhardt R, Strauss A, Stockel M, Langer C, Freudenthal K (1983) The syndrome scales in the AMDP-system. Mod Probl Pharmacopsychiatry 20:88-99
42. Schonell H (1988) Efficiency of the AMDP anamnestic data in psychiatric research. Pharmacopsychiatry 21(6), 456-7
43. Shepherd M, Watt D, Falloon I, Smeeton N (1989) The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychol Med Monogr Suppl 15:1-46
44. Singer CA, Rogers KL, Dorsa DM (1998) Modulation of Bcl-2 expression a potential component of estrogen protection in NT2 neurons. Neuroreport 3; 9(11):2565-8
45. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J et al. (1995) Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 152(5):698-703
46. Spitzer J, Endicott RJ, Fleiss L (1976) The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbances. Arch Gen Psychiatry 33:766-771
47. Strauss JS, Carpenter WT Jr (1977) Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Arch Gen Psychiatry 34(2):159-63
48. Westermeyer JF, Harrow M (1984) Prognosis and outcome using broad (DSM-II) and narrow (DSM-III) concepts of schizophrenia. Schizophr Bull 10(4):624-37
49. Wieselgren IM, Lindstrom E, Lindstrom LH (1996) Symptoms at index admission as predictor for 1-5 year outcome in schizophrenia. Acta Psychiatr Scand 94(5):311-9
50. Wyatt RJ (1991) Neuroleptics and the natural course of schizophrenia. Schizophr Bull 17(2):325-51